1
|
Muacevic A, Adler JR, LeQuang JAK, Breve F, Magnusson P. Fixed Dose Versus Loose Dose: Analgesic Combinations. Cureus 2023; 15:e33320. [PMID: 36741676 PMCID: PMC9894647 DOI: 10.7759/cureus.33320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Accepted: 12/23/2022] [Indexed: 01/05/2023] Open
Abstract
Combinations of drugs may be fixed (two or more entities in a single product) or loose (two or more agents taken together but as individual agents) to help address multimechanistic pain. The use of opioids plus nonopioids can result in lower opioid consumption without sacrificing analgesic benefits. Drug combinations may offer additive or synergistic benefits. A variety of fixed-dose combination products are available on the market such as diclofenac plus thiocolchicoside, acetaminophen and caffeine, acetaminophen and opioid, ibuprofen and acetaminophen, tramadol and acetaminophen, and others. Fixed-dose combination products offer predictable pharmacokinetics and pharmacodynamics, known adverse events, and can reduce the pill burden. However, they are limited to certain drug combinations and doses; loose dosing allows prescribers the versatility to meet individual patient requirements as well as the ability to titrate as needed. Not all drug combinations offer synergistic benefits, which depend on the drugs and their doses. Certain drugs offer dual mechanisms of action in a single molecule, such as tapentadol, and these may further be used in combination with other analgesics. New technology allows for co-crystal productions of analgesic agents which may further improve drug characteristics, such as bioavailability. Combination analgesics are important additions to the analgesic armamentarium and may offer important benefits at lower doses than monotherapy.
Collapse
|
2
|
Huang S, Venables DS, Lawrence SE. Pharmaceutical Salts of Piroxicam and Meloxicam with Organic Counterions. CRYSTAL GROWTH & DESIGN 2022; 22:6504-6520. [PMID: 36817751 PMCID: PMC9933440 DOI: 10.1021/acs.cgd.2c00722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/27/2022] [Revised: 10/13/2022] [Indexed: 06/18/2023]
Abstract
Piroxicam (PRM) and meloxicam (MEL) are two nonsteroidal anti-inflammatory drugs, belonging to the Biopharmaceutics Classification System Class II drugs. In this study, six novel pharmaceutical salts of PRM and MEL with three basic organic counterions, that is, 4-aminopyridine (4AP), 4-dimethylaminopyridine (4DMP), and piperazine (PPZ), were prepared by both slurrying and slow evaporation. These salts were characterized by single-crystal and powder X-ray diffraction, thermal analysis, and Fourier transform infrared spectroscopy. All six salts, especially MEL-4DMP and MEL-4AP, showed a significantly improved apparent solubility and dissolution rate in sodium phosphate solution compared with the pure APIs. Notably, PRM-4AP and PRM-4DMP salts exhibited enhanced fluorescence, and the PRM-PPZ salt showed weaker fluorescence compared with that of pure PRM due to different luminescence mechanisms.
Collapse
Affiliation(s)
- Shan Huang
- School
of Chemistry, Analytical and Biological Chemistry Research Facility,
Synthesis and Solid State Pharmaceutical Centre, University College Cork, Cork T12 K8AF, Ireland
| | - Dean S. Venables
- School
of Chemistry and Environmental Research Institute, University College Cork, Cork T12 K8AF, Ireland
| | - Simon E. Lawrence
- School
of Chemistry, Analytical and Biological Chemistry Research Facility,
Synthesis and Solid State Pharmaceutical Centre, University College Cork, Cork T12 K8AF, Ireland
| |
Collapse
|
3
|
Emami S, Shayanfar A. Comments on "Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization". Adv Pharm Bull 2021; 11:578-579. [PMID: 34513634 PMCID: PMC8421615 DOI: 10.34172/apb.2021.067] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2019] [Accepted: 05/23/2020] [Indexed: 01/02/2023] Open
Affiliation(s)
- Shahram Emami
- School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran
| | - Ali Shayanfar
- Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
| |
Collapse
|
4
|
Al-Obaidi H, Granger A, Hibbard T, Opesanwo S. Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions. Pharmaceutics 2021; 13:1056. [PMID: 34371747 PMCID: PMC8309119 DOI: 10.3390/pharmaceutics13071056] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 07/05/2021] [Accepted: 07/06/2021] [Indexed: 01/03/2023] Open
Abstract
It is well established that currently available inhaled drug formulations are associated with extremely low lung deposition. Currently available technologies alleviate this low deposition problem via mixing the drug with inert larger particles, such as lactose monohydrate. Those inert particles are retained in the inhalation device or impacted in the throat and swallowed, allowing the smaller drug particles to continue their journey towards the lungs. While this seems like a practical approach, in some formulations, the ratio between the carrier to drug particles can be as much as 30 to 1. This limitation becomes more critical when treating lung conditions that inherently require large doses of the drug, such as antibiotics and antivirals that treat lung infections and anticancer drugs. The focus of this review article is to review the recent advancements in carrier free technologies that are based on coamorphous solid dispersions and cocrystals that can improve flow properties, and help with delivering larger doses of the drug to the lungs.
Collapse
Affiliation(s)
- Hisham Al-Obaidi
- The School of Pharmacy, University of Reading, Reading RG6 6AD, UK; (A.G.); (T.H.); (S.O.)
| | | | | | | |
Collapse
|
5
|
Garg U, Azim Y. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs. RSC Med Chem 2021; 12:705-721. [PMID: 34124670 PMCID: PMC8152597 DOI: 10.1039/d0md00400f] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Accepted: 01/22/2021] [Indexed: 01/14/2023] Open
Abstract
The focus of the review is to discuss the relevant and essential aspects of pharmaceutical cocrystals in both academia and industry with an emphasis on non-steroidal anti-inflammatory drugs (NSAIDs). Although cocrystals have been prepared for a plethora of drugs, NSAID cocrystals are focused due to their humongous application in different fields of medication such as antipyretic, anti-inflammatory, analgesic, antiplatelet, antitumor, and anti-carcinogenic drugs. The highlights of the review are (a) background of cocrystals and other solid forms of an active pharmaceutical ingredient (API) based on the principles of crystal engineering, (b) why cocrystals are an excellent opportunity in the pharma industry, (c) common methods of preparation of cocrystals from the lab scale to bulk quantity, (d) some latest case studies of NSAIDs which have shown better physicochemical properties for example; mechanical properties (tabletability), hydration, solubility, bioavailability, and permeability, and (e) latest guidelines of the US FDA and EMA opening new opportunities and challenges.
Collapse
Affiliation(s)
- Utsav Garg
- Department of Applied Chemistry, Zakir Husain College of Engineering & Technology, Faculty of Engineering & Technology, Aligarh Muslim University Aligarh 202002 Uttar Pradesh India
| | - Yasser Azim
- Department of Applied Chemistry, Zakir Husain College of Engineering & Technology, Faculty of Engineering & Technology, Aligarh Muslim University Aligarh 202002 Uttar Pradesh India
| |
Collapse
|
6
|
Solares-Briones M, Coyote-Dotor G, Páez-Franco JC, Zermeño-Ortega MR, de la O Contreras CM, Canseco-González D, Avila-Sorrosa A, Morales-Morales D, Germán-Acacio JM. Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals. Pharmaceutics 2021; 13:790. [PMID: 34070646 PMCID: PMC8228148 DOI: 10.3390/pharmaceutics13060790] [Citation(s) in RCA: 40] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2021] [Revised: 05/07/2021] [Accepted: 05/10/2021] [Indexed: 11/17/2022] Open
Abstract
Mechanochemistry is considered an alternative attractive greener approach to prepare diverse molecular compounds and has become an important synthetic tool in different fields (e.g., physics, chemistry, and material science) since is considered an ecofriendly procedure that can be carried out under solvent free conditions or in the presence of minimal quantities of solvent (catalytic amounts). Being able to substitute, in many cases, classical solution reactions often requiring significant amounts of solvents. These sustainable methods have had an enormous impact on a great variety of chemistry fields, including catalysis, organic synthesis, metal complexes formation, preparation of multicomponent pharmaceutical solid forms, etc. In this sense, we are interested in highlighting the advantages of mechanochemical methods on the obtaining of pharmaceutical cocrystals. Hence, in this review, we describe and discuss the relevance of mechanochemical procedures in the formation of multicomponent solid forms focusing on pharmaceutical cocrystals. Additionally, at the end of this paper, we collect a chronological survey of the most representative scientific papers reporting the mechanochemical synthesis of cocrystals.
Collapse
Affiliation(s)
- Mizraín Solares-Briones
- Red de Apoyo a la Investigación, Coordinación de la Investigación Científica-UNAM, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Ciudad de México, C.P. 14000, Mexico; (M.S.-B.); (G.C.-D.); (J.C.P.-F.)
| | - Guadalupe Coyote-Dotor
- Red de Apoyo a la Investigación, Coordinación de la Investigación Científica-UNAM, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Ciudad de México, C.P. 14000, Mexico; (M.S.-B.); (G.C.-D.); (J.C.P.-F.)
| | - José C. Páez-Franco
- Red de Apoyo a la Investigación, Coordinación de la Investigación Científica-UNAM, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Ciudad de México, C.P. 14000, Mexico; (M.S.-B.); (G.C.-D.); (J.C.P.-F.)
| | - Miriam R. Zermeño-Ortega
- Facultad de Ciencias Químicas, Universidad Autónoma de Chihuahua, Circuito Universitario No. 1, Nuevo Campus Universitario, Apdo. Postal 1552, Chihuahua, C.P. 31125, Mexico; (M.R.Z.-O.); (C.M.d.l.OC.)
| | - Carmen Myriam de la O Contreras
- Facultad de Ciencias Químicas, Universidad Autónoma de Chihuahua, Circuito Universitario No. 1, Nuevo Campus Universitario, Apdo. Postal 1552, Chihuahua, C.P. 31125, Mexico; (M.R.Z.-O.); (C.M.d.l.OC.)
| | - Daniel Canseco-González
- CONACYT-Laboratorio Nacional de Investigación y Servicio Agroalimentario y Forestal, Universidad Autónoma de Chapingo, Texcoco de Mora, C.P. 56230, Mexico;
| | - Alcives Avila-Sorrosa
- Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Departamento de Química Orgánica, Carpio y Plan de Ayala S/N, Colonia Santo Tomás, Ciudad de México, C.P. 11340, Mexico;
| | - David Morales-Morales
- Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Ciudad de México, C.P. 04510, Mexico
| | - Juan M. Germán-Acacio
- Red de Apoyo a la Investigación, Coordinación de la Investigación Científica-UNAM, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Ciudad de México, C.P. 14000, Mexico; (M.S.-B.); (G.C.-D.); (J.C.P.-F.)
| |
Collapse
|
7
|
Ouiyangkul P, Tantishaiyakul V, Hirun N. Exploring potential coformers for oxyresveratrol using principal component analysis. Int J Pharm 2020; 587:119630. [DOI: 10.1016/j.ijpharm.2020.119630] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 06/25/2020] [Accepted: 07/06/2020] [Indexed: 01/27/2023]
|
8
|
Emami S, Shayanfar A. Deep eutectic solvents for pharmaceutical formulation and drug delivery applications. Pharm Dev Technol 2020; 25:779-796. [DOI: 10.1080/10837450.2020.1735414] [Citation(s) in RCA: 44] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Shahram Emami
- Department of Pharmaceutics, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran
| | - Ali Shayanfar
- Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
| |
Collapse
|
9
|
Solaimalai R, Shinde G, Dharamsi A, Kokare C. Exploring the novel green eutectic solvent for the synthesis of 4-hydroxy-2-methyl- N-2-pyridinyl-2 H-1,2,-benzothiazine-3-carboxamide 1,1-dioxide with benzoic acid cocrystal using a co-grinding technique. NEW J CHEM 2020. [DOI: 10.1039/d0nj03570j] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
In the present study, the suitability of a green eutectic solvent, a mixture of menthol and camphor for cocrystal synthesis has been investigated to improve the biopharmaceutical properties of poorly water-soluble drugs.
Collapse
Affiliation(s)
- Rajalakshmi Solaimalai
- Department of Pharmaceutics
- Parul Institute of Pharmacy
- Parul University
- Vadodara-391760
- India
| | | | - Abhay Dharamsi
- Department of Pharmaceutics
- Parul Institute of Pharmacy
- Parul University
- Vadodara-391760
- India
| | - Chandrakant Kokare
- Department of Pharmaceutics
- Sinhgad Institute of Pharmacy
- Pune-411041
- India
| |
Collapse
|
10
|
Gautam MK, Besan M, Pandit D, Mandal S, Chadha R. Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters. AAPS PharmSciTech 2019; 20:149. [PMID: 30903402 DOI: 10.1208/s12249-019-1360-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Accepted: 03/05/2019] [Indexed: 02/08/2023] Open
Abstract
To prepare the cocrystals of 5-fluorouracil (5-FU) with GRAS status coformers via a cocrystallization technique with an aim to improve physicochemical properties as well as bioavailability for colon cancer, breast cancer, and prostate cancer. The mechanochemical method was used in the preparations of three crystals of 5-FU with gentisic acid (5-FUGA), 3,4-dihydroxybenzoic acid (5-FUBA), and 4-aminopyridine (5-FUPN). A thermoanalytical and spectroscopic technique was used for their characterization. Their biological evaluation was done in different cancer cell lines. The new solid pure crystal forms were characterized by DSC, FTIR, and PXRD. The crystal structure was determined from single crystal and PXRD that exposed the existence of the monoclinic and triclinic crystal system with P21/n and P-1 space groups. The dermatokinetic studies on the rat skin revealed two- to threefold improvement in relative bioavailability as compared to pure 5-FU. "MTT assay was performed by varying the concentrations of the drug from 1 to 50 μg mL-1. After 24 h, the cell viability dropped to 70.67%, 74.05%, and 76.37% in MCF-7, Hela, and Caco-2 cell lines when the concentration of 5-FU was 50 μg mL-1", while it dropped dramatically in cocrystals 5-FUGA (22.06%, 24.63%, and 25.61%), 5-FUBA (31.22%, 29.46%, and 32.81%), and 5-FUPN (21.65%, 32.64%, and 21.46%). All the results indicated that 5-FU cocrystals possess better antitumor efficacy than free drug. Thus, cocrystallization expands the extent of the existing pre-formulation options ahead of pure API form to ameliorate the bioavailability and permeability.
Collapse
|
11
|
Liu X, Michalchuk AAL, Pulham CR, Boldyreva EV. An acetonitrile-solvated cocrystal of piroxicam and succinic acid with co-existing zwitterionic and non-ionized piroxicam molecules. ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY 2019; 75:29-37. [PMID: 30601128 DOI: 10.1107/s2053229618016911] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2018] [Accepted: 11/28/2018] [Indexed: 11/10/2022]
Abstract
This work reports a new acetonitrile (ACN)-solvated cocrystal of piroxicam (PRX) and succinic acid (SA), 2C15H13N3O4S·0.5C4H6O4·C2H3N or PRX:SA:ACN (4:1:2), which adopts the triclinic space group P-1. The outcome of crystallization from ACN solution can be controlled by varying only the PRX:SA ratio, with a higher PRX:SA ratio in solution unexpectedly favouring a lower stoichiometric ratio in the solid product. In the new solvate, zwitterionic (Z) and non-ionized (NI) PRX molecules co-exist in the asymmetric unit. In contrast, the nonsolvated PRX-SA cocrystal contains only NI-type PRX molecules. The ACN molecule entrapped in PRX-SA·ACN does not form any hydrogen bonds with the surrounding molecules. In the solvated cocrystal, Z-type molecules form dimers linked by intermolecular N-H...O hydrogen bonds, whereas every pair of NI-type molecules is linked to SA via N-H...O and O-H...N hydrogen bonds. Thermogravimetry and differential scanning calorimetry suggest that thermal desolvation of the solvate sample occurs at 148 °C, and is followed by recrystallization, presumably of a multicomponent PRX-SA structure. Vibrational spectra (IR and Raman spectroscopy) of PRX-SA·ACN and PRX-SA are also used to demonstrate the ability of spectroscopic techniques to distinguish between NI- and Z-type PRX molecules in the solid state. Hence, vibrational spectroscopy can be used to distinguish the PRX-SA cocrystal and its ACN solvate.
Collapse
Affiliation(s)
- Xiaojiao Liu
- EaStCHEM School of Chemistry and Centre for Science at Extreme Conditions, University of Edinburgh, Joseph Black Building, Edinburgh EH9 3FJ, Scotland
| | - Adam A L Michalchuk
- EaStCHEM School of Chemistry and Centre for Science at Extreme Conditions, University of Edinburgh, Joseph Black Building, Edinburgh EH9 3FJ, Scotland
| | - Colin R Pulham
- EaStCHEM School of Chemistry and Centre for Science at Extreme Conditions, University of Edinburgh, Joseph Black Building, Edinburgh EH9 3FJ, Scotland
| | - Elena V Boldyreva
- Boreskov Institute of Catalysis, Siberian Branch of Russian Academy of Sciences, pr. Lavrentieva 5, Novosibirisk 630090, Russian Federation
| |
Collapse
|
12
|
Arkhipov SG, Sherin PS, Kiryutin AS, Lazarenko VA, Tantardini C. The role of S-bond in tenoxicam keto–enolic tautomerization. CrystEngComm 2019. [DOI: 10.1039/c9ce00874h] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A non-covalent interaction between the sulphur atom of thiophenyl moiety and oxygen of the carbonyl group (S-bond) plays a crucial role in keto–enol tautomerization of tenoxicam leading to the crystallization of latter only in zwitterionic (ZWC) and not in β-keto–enolic (BKE) form.
Collapse
Affiliation(s)
- Sergey G. Arkhipov
- Novosibirsk State University
- 630090 Novosibirsk
- Russian Federation
- Boreskov Institute of Catalysis SB RAS
- 630090 Novosibirsk
| | - Peter S. Sherin
- Novosibirsk State University
- 630090 Novosibirsk
- Russian Federation
- International Tomography Center
- 630090 Novosibirsk
| | - Alexey S. Kiryutin
- Novosibirsk State University
- 630090 Novosibirsk
- Russian Federation
- International Tomography Center
- 630090 Novosibirsk
| | | | - Christian Tantardini
- Center for Energy Science and Technology
- Skoltech Skolkovo Institute of Science and Technology
- 143026 Moscow
- Russian Federation
| |
Collapse
|
13
|
Li D, Li J, Deng Z, Zhang H. Piroxicam–clonixin drug–drug cocrystal solvates with enhanced hydration stability. CrystEngComm 2019. [DOI: 10.1039/c9ce00666d] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Piroxicam and clonixin can form drug–drug crystalline complexes with the help of suitable solvent molecules.
Collapse
Affiliation(s)
- Duanxiu Li
- Laboratory of Magnetic Resonance Spectroscopy and Imaging
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| | - Jiong Li
- CAS Key Laboratory of Nano-Bio Interface
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| | - Zongwu Deng
- Laboratory of Magnetic Resonance Spectroscopy and Imaging
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| | - Hailu Zhang
- Laboratory of Magnetic Resonance Spectroscopy and Imaging
- Suzhou Institute of Nano-Tech and Nano-Bionics
- Chinese Academy of Sciences
- Suzhou 215123
- P. R. China
| |
Collapse
|
14
|
Emami S, Siahi-Shadbad M, Adibkia K, Barzegar-Jalali M. Recent advances in improving oral drug bioavailability by cocrystals. ACTA ACUST UNITED AC 2018; 8:305-320. [PMID: 30397585 PMCID: PMC6209825 DOI: 10.15171/bi.2018.33] [Citation(s) in RCA: 50] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2018] [Revised: 05/04/2018] [Accepted: 05/05/2018] [Indexed: 12/18/2022]
Abstract
![]()
Introduction: Oral drug delivery is the most favored route of drug administration. However, poor oral bioavailability is one of the leading reasons for insufficient clinical efficacy. Improving oral absorption of drugs with low water solubility and/or low intestinal membrane permeability is an active field of research. Cocrystallization of drugs with appropriate coformers is a promising approach for enhancing oral bioavailability.
Methods: In the present review, we have focused on recent advances that have been made in improving oral absorption through cocrystallization. The covered areas include supersaturation and its importance on oral absorption of cocrystals, permeability of cocrystals through membranes, drug-coformer pharmacokinetic (PK) interactions, conducting in vivo-in vitro correlations for cocrystals. Additionally, a discussion has been made on the integration of nanocrystal technology with supramolecular design. Marketed cocrystal products and PK studies in human subjects are also reported.
Results: Considering supersaturation and consequent precipitation properties is necessary when evaluating dissolution and bioavailability of cocrystals. Appropriate excipients should be included to control precipitation kinetics and to capture solubility advantage of cocrystals. Beside to solubility, cocrystals may modify membrane permeability of drugs. Therefore, cocrystals can find applications in improving oral bioavailability of poorly permeable drugs. It has been shown that cocrystals may interrupt cellular integrity of cellular monolayers which can raise toxicity concerns. Some of coformers may interact with intestinal absorption of drugs through changing intestinal blood flow, metabolism and inhibiting efflux pumps. Therefore, caution should be taken into account when conducting bioavailability studies. Nanosized cocrystals have shown a high potential towards improving absorption of poorly soluble drugs.
Conclusions: Cocrystals have found their way from the proof-of-principle stage to the clinic. Up to now, at least two cocrystal products have gained approval from regulatory bodies. However, there are remaining challenges on safety, predicting in vivo behavior and revealing real potential of cocrystals in the human.
Collapse
Affiliation(s)
- Shahram Emami
- Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.,Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Mohammadreza Siahi-Shadbad
- Department of Pharmaceutical and Food Control, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Khosro Adibkia
- Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
| | - Mohammad Barzegar-Jalali
- Biotechnology Research Center, and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
| |
Collapse
|